IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16 | -33.3% | 3,681 | +4.1% | 0.00% | – |
| Q2 2023 | $24 | +20.0% | 3,535 | +3.3% | 0.00% | – |
| Q1 2023 | $20 | +17.6% | 3,421 | +25.7% | 0.00% | – |
| Q4 2022 | $17 | -99.9% | 2,722 | -22.1% | 0.00% | – |
| Q3 2022 | $32,000 | -13.5% | 3,492 | +0.5% | 0.00% | – |
| Q2 2022 | $37,000 | -32.7% | 3,474 | +3.5% | 0.00% | – |
| Q1 2022 | $55,000 | +19.6% | 3,357 | +38.5% | 0.00% | – |
| Q4 2021 | $46,000 | -4.2% | 2,423 | +21.3% | 0.00% | – |
| Q3 2021 | $48,000 | -37.7% | 1,998 | -33.5% | 0.00% | – |
| Q2 2021 | $77,000 | +7600.0% | 3,006 | +4827.9% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 61 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | – | 61 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |